| 标题 |
Updated Health-Related Quality of Life Results from the KarMMa Clinical Study in Patients with Relapsed and Refractory Multiple Myeloma Treated with the B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Idecabtagene Vicleucel (ide-cel, bb2121) |
| 网址 | |
| DOI |
10.1182/blood-2021-145155
doi
|
| 其它 |
期刊:Blood 作者:Michel Delforge; Nina Shah; Paula Rodríguez-Otero; Julia Braverman; Devender Dhanda; et al 出版日期:2021-11-05 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)